20.66
Schlusskurs vom Vortag:
$20.81
Offen:
$20.8
24-Stunden-Volumen:
841.10K
Relative Volume:
0.29
Marktkapitalisierung:
$5.28B
Einnahmen:
$810.81M
Nettoeinkommen (Verlust:
$156.02M
KGV:
32.69
EPS:
0.6319
Netto-Cashflow:
$373.47M
1W Leistung:
-1.08%
1M Leistung:
-1.92%
6M Leistung:
+0.02%
1J Leistung:
+8.15%
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SBRA
Sabra Healthcare Reit Inc
|
20.66 | 5.32B | 810.81M | 156.02M | 373.47M | 0.6319 |
|
WELL
Welltower Inc
|
236.09 | 170.96B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
VTR
Ventas Inc
|
89.11 | 46.10B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
OHI
Omega Healthcare Investors Inc
|
46.62 | 14.25B | 1.24B | 655.98M | 857.80M | 2.063 |
|
DOC
Healthpeak Properties Inc
|
20.22 | 14.14B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
AHR
American Healthcare Reit Inc
|
53.77 | 11.90B | 2.37B | 101.67M | 169.19M | 0.5775 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference - Business Wire
309,853 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al - marketbeat.com
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Wellington Management Group LLP - marketbeat.com
Hsbc Holdings PLC Boosts Holdings in Sabra Healthcare REIT, Inc. $SBRA - marketbeat.com
CEO of Sabra (NASDAQ: SBRA) lines up $4.15M stock sale - Stock Titan
Readystate Asset Management LP Makes New $1.40 Million Investment in Sabra Healthcare REIT, Inc. $SBRA - marketbeat.com
Sabra Health Care REIT (SBRA) director now holds 117,137 stock units - Stock Titan
Sabra Health Care REIT (SBRA) director granted dividend stock units - Stock Titan
Director at Sabra (NASDAQ: SBRA) now holds 86,912 stock units after latest grant - Stock Titan
Sabra (NASDAQ: SBRA) director now holds 82,834 stock units - Stock Titan
Sabra Health Care REIT (SBRA) director gains 791 stock units via dividend credit - Stock Titan
Dividend credits add 791 units to Sabra (SBRA) director’s stake - Stock Titan
Sabra Health Care REIT (SBRA) CEO holds 956,268 units and 1,857,686 shares - Stock Titan
Headlands Technologies LLC Has $1.32 Million Position in Sabra Healthcare REIT, Inc. $SBRA - marketbeat.com
Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Robert W. Baird Analyst Says - marketbeat.com
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - marketbeat.com
SBRA Q2 2026 Earnings: Steep EPS Miss of 156.72% Met With 2.37% Share GainEarnings Preview - vinanet.vn
Sabra Healthcare REIT Earnings Call Signals Steady Growth - The Globe and Mail
Sabra Health Care REIT (SBRA) Advances 2.37% to $20.32, Pressing Toward Resistance at $21.34Synthetic Long - vinanet.vn
Sabra Health Care REIT, Inc. (SBRA) Stock forecasts - Yahoo Finance Singapore
Sabra Health Care REIT, Inc. (SBRA) Stock Forecasts - Yahoo Finance
Sabra Health Care REIT (SBRA) Slides Nearly 4% as Rate Concerns Weigh on Healthcare REITsRating Change - Vinanet
How Investors May Respond To Sabra Health Care REIT (SBRA) Profit Reversal And Steady Dividend - simplywall.st
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript - AOL.com
Quantinno Capital Management LP Grows Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Bank of America Corp DE - MarketBeat
Sabra Health Care REIT, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SBRA) 2026-08-07 - Seeking Alpha
California State Teachers Retirement System Grows Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Health Care REIT (SBRA) Nudges Up to $20.98 as Support Holds FirmStock Analysis - vinanet.vn
Raymond James upgrades Sabra Healthcare stock on tenant transitions By Investing.com - Investing.com Australia
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation - Yahoo Finance
Raymond James upgrades Sabra Healthcare stock on tenant transitions - Investing.com
Analysts Offer Insights on Real Estate Companies: Alexandria Equities (ARE) and Sabra Healthcare REIT (SBRA) - The Globe and Mail
Sabra Healthcare REIT Reports Q2 2026 Results, Growth Investments - The Globe and Mail
Sabra Healthcare REIT Q2 Earnings Call Highlights - marketbeat.com
Earnings call transcript: Sabra Health Care REIT misses Q2 2026 EPS, beats revenue - Investing.com
Sabra Health Care REIT (SBRA) Holds at $20.66 as Support and Resistance Frame Near-Term TradingTriple Bottom - vinanet.vn
Truist upgrades Sabra Health Care REIT to Buy, keeps $22 target - scanx.trade
Analysts raise Sabra Health Care REIT targets to $24, $23 - scanx.trade
Sabra Health Care REIT Q2 Revenue Beats Estimates, AFFO Rises to $0.40 - scanx.trade
Sabra: Q2 Earnings Snapshot - KGW
Loan write-off drives quarterly loss at Sabra Health Care REIT (NASDAQ: SBRA) - Stock Titan
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? By Investing.com - Investing.com South Africa
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? - Investing.com India
Janus Henderson Group PLC Reduces Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
SBRA Q1 2026 Earnings: EPS Misses Estimates by 5.3% as Shares Slip 0.7%Post-Earnings Reaction - vinanet.vn
Sei Investments Co. Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
SBRA Q1 2026 Earnings: EPS Misses Estimates, Stock Declines SlightlyFree Cash Flow Trends - vinanet.vn
First Trust Advisors LP Raises Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sabra Healthcare Reit Inc-Aktie (SBRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FLORES JESSICA | Executive VP & CAO |
Mar 25 '26 |
Sale |
19.86 |
15,231 |
302,488 |
71,709 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):